Comparison of Antibacterial Activities of Tobramycin Inhalation Solutions
Abstract
Antibacterial spectra of Tobramycin-Gobby(solution for inhalation 60 mg/ml, «GobbyNovag C.A.», Argentina) and Toby (solution for inhalation 60 mg/ml, «Cardinal Health Inc.», USA) were estimated comparatively. The estimation involved 75 clinical isolates of microorganisms from the Culture Collection of the National Research Centre of Antibiotics and standard strains of Staphylococcus aureus АТСС 29213, Escherichia coli АТСС 25922, Pseudomonas aeruginosa АТСС 27853.It was shown that Tobramycin-Gobby (solution for inhalation 60 mg/ml, «GobbyNovag C.A.», Argentina) and Toby (solution for inhalation 60 mg/ml, «Cardinal Health Inc.», USA) were identical by their antibacterial spectra.
References
1. Dudley M.N., Loutit J., Griffith D.C. Aerosol antibiotics: considerations in pharmacological and clinical evaluation. Curr Opin Biotechnol 2008, 19: 637-643.
2. Ramsey B.W., Pepe M.S., Quan J.M. et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. New Engl J Med 1999; 340: 23-30.
3. Методические указания по определению чувствительности микроорганизмов к антибактериальным препаратам. МУК 4.2.1890-04. М.: 2004.
4. Амелина Е.Л., Черняк А.В., Чучалин А.Г. Пульмонология. Приложение по муковисцидозу. 2006; 30-39.
5. Mesa Española de Normalizatión de la Sensibilidad y Resistencia a los Antimicrobianos. Recomendaciones del grupo MENSURA para la selectión de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretatión del antibiograma. MENSURA, Madrid, Spain. 2005.
Review
For citations:
Pisarev V.V. Comparison of Antibacterial Activities of Tobramycin Inhalation Solutions. Antibiot Khimioter = Antibiotics and Chemotherapy. 2013;58(3-4):19-21. (In Russ.)
Views:
383
Email this article 